Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126870471 | 12687047 | 1 | I | 20160819 | 20160826 | 20160826 | EXP | BR-ROCHE-1818057 | ROCHE | 66.00 | YR | M | Y | 0.00000 | 20160826 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126870471 | 12687047 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Unknown | 125085 | |||||||||||
| 126870471 | 12687047 | 2 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 3 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 4 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 7 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 8 | SS | Irinotecan | IRINOTECAN | 1 | Unknown | 0 | |||||||||||
| 126870471 | 12687047 | 9 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126870471 | 12687047 | 1 | Product used for unknown indication |
| 126870471 | 12687047 | 2 | Product used for unknown indication |
| 126870471 | 12687047 | 5 | Product used for unknown indication |
| 126870471 | 12687047 | 8 | Product used for unknown indication |
| 126870471 | 12687047 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126870471 | 12687047 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126870471 | 12687047 | Hepatic neoplasm | |
| 126870471 | 12687047 | Neuropathy peripheral | |
| 126870471 | 12687047 | Nodule | |
| 126870471 | 12687047 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126870471 | 12687047 | 1 | 20140205 | 20151207 | 0 | |
| 126870471 | 12687047 | 2 | 20140205 | 20151207 | 0 | |
| 126870471 | 12687047 | 3 | 20100806 | 0 | ||
| 126870471 | 12687047 | 4 | 20111212 | 0 | ||
| 126870471 | 12687047 | 5 | 20140205 | 20151207 | 0 | |
| 126870471 | 12687047 | 6 | 20100806 | 0 | ||
| 126870471 | 12687047 | 7 | 20111212 | 0 | ||
| 126870471 | 12687047 | 8 | 20140205 | 20151207 | 0 | |
| 126870471 | 12687047 | 9 | 20111212 | 0 |